Background. New and more potent immunosuppressive protocols have markedly reduced the occurrence of rejections following organ transplantation. Accordingly, survival of elderly kidney transplant recipients has been substantially improved in the new millennium. The present study was performed to identify variables associated with the outcome of kidney transplant recipients >70 years of age in the modern era. Methods. A single center retrospective study was performed, evaluating clinical and survival data from all patients >70 years of age receiving their first kidney transplant between 2000 and 2005. Survival data were analyzed using Cox proportional hazard models and the KaplanMeier method. Results. During the time period, 160 recipients >70 years of age received their first transplant. The following factors were negatively associated with patient survival: age at transplantation; hazard ratio (HR) 1.09 per year, 95% confidence interval (CI) (1.01-1.18), time on dialysis before transplantation; HR 1.29 per year 95% CI (1.06-1.59) and presence of diabetes at transplantation; HR 1.78 95% CI (1.00-3.16). Thirty-five patients (22%) experienced an acute rejection episode during the first 90 days posttransplant. Acute rejection episodes did not influence on patient or graft survival. Patients with post-transplant pathological oral glucose tolerance test (OGTT) at 10 weeks after transplantation had significantly inferior survival compared to patients with normal OGTT. Conclusions. In a population of kidney transplant recipients >70 years of age with relatively low incidence of acute rejection episodes, age, time on dialysis before transplantation, concomitant diabetes mellitus and development of a pathological OGTT 10 weeks after transplantation were associated with inferior patient survival.
Introduction
Kidney transplantation is generally considered to be the best treatment of end-stage renal disease (ESRD), also in elderly recipients [1] [2] [3] [4] [5] [6] . Comorbidity and in particular, the presence of cardiovascular disease, at the time of transplantation, have previously been identified as risk variables in a population of adult kidney transplant recipients [7] . In addition, among adult patients, pre-existing diabetes mellitus (DM) has been found to be associated with premature death after kidney transplantation [8] , while new onset diabetes after transplantation (NODAT) has been related to increased risk of major cardiovascular events [9] . In a previously published historic material, we have described variables associated with the outcome of kidney transplant recipients >70 years of age [10] . We were not able to find any association between the outcome and pre-transplant DM, ischemic heart disease or comorbidity in general described by the Charlson comorbidity index [11] . On the other hand, patient survival was strongly associated with the presence of an acute rejection episode, advanced donor age and time on dialysis before transplantation [10] . With the introduction of modern immunosuppressive regimes, which took place at our hospital in 2000, the acute rejection rate in elderly recipients has declined and the survival of elderly recipients after transplantation compared to patients continuing on dialysis has improved [6] . To investigate if the decrease in acute rejection rate has altered the previously observed association between clinical variables and patient survival, we aimed to perform a new analysis focusing on patients transplanted after 2000, i.e. recipients treated according to a modern immunosuppressive protocol. In addition, we investigated if DM at transplantation or development of impaired glucose tolerance (IGT)/NO-DAT after transplantation would affect survival of elderly kidney recipients receiving modern immunosuppressive medication.
Materials and methods
Survival data of all patients !70 years of age who received their first single kidney transplant at our transplant center from 2000 throughout 2005 were retrieved from the Norwegian Renal Registry. End of follow-up was set at 18 December 2009. Standard immunosuppressive therapy consisted of cyclosporine (CsA) and steroids. CsA was at that time monitored by C2 concentrations for the first 3 months and thereafter by C0 (initial dose 10 mg/kg/day; C2 target concentration 1500-2000 lmol/L for the first month, 1400-1600 lmol/L for Month 2 and 1000-1200 lmol/L for Month 3; thereafter C0-target of 75-200 lmol/L). Steroids were tapered from an initial dose of prednisolone 80 mg/day, to 20 mg/day at 1 week, 10 mg/day after 3 months and then further tapering toward 5 mg/day. In addition, induction therapy with the interleukin 2 receptor antagonist basiliximab (IL2R-ab) was used in 2000. From 2001, patients received a triple immunosuppressive regimen consisting of mycophenolate mofetil (MMF) 1000 mg b.i.d., CsA and steroids.
Clinical variables previously identified as risk factors for patient death or graft loss [10] , and additional variables with suspect association to patient or graft survival, were retrieved from the registry and hospital records. Comorbidity at transplantation was quantified retrospectively using the Charlson Comorbidity Index as described in a previous publication [10] . All patients were offered a post-transplant follow-up for 10 weeks at the National Hospital. The patients were generally hospitalized for 6-8 days and then discharged to a hospital hotel and followed-up in an outpatients' clinic. If the patients were unable to take care of themselves (for various reasons), they remained hospitalized and were transferred to their local hospital 4-6 weeks after transplantation. According to our local protocol, an oral glucose tolerance test (OGTT) is to be performed 10 weeks after transplantation.
Statistics
Two-sided unpaired t-test or Mann-Whitney test was used as appropriate to compare groups. Fisher's exact test was used to analyze binary data.
Survival was estimated using the Kaplan-Meier method. Because of a relatively low number of patients performing OGTT at 10 weeks, we restricted the comparative survival analysis to include patients with normal OGTT and a combined group of patients with pathological OGTT comprising patients with IGT and patients with NODAT. Additional survival analyses were also performed on the total material, comparing patients with pre-existing DM and pre-transplant non-diabetic patients. Events were defined as patient death, death censored graft loss and uncensored graft loss. Potential risk variables associated with patient and graft survival were assessed in Cox proportional hazard regression models. All variables were first analyzed in a univariable Cox regression model. Variables with P-value < 0.2 in the univariable analysis were implemented into a multivariable model. In addition, we also added the presence of early acute rejection (first 90 days after transplantation) to the multivariable model as this variable was highly significant in our previous analyses [10] . Patient survival was defined as time from transplantation to patient death or censoring due to end of study. Graft survival was defined as time from transplantation to death or graft loss. In addition, graft loss censored for death with functioning graft was analyzed separately. There were no missing data. The analyses were implemented using SPSSÒ 15.0.
Results
From January 2000 to December 2005, 160 patients (112 male/48 female) beyond 70 years of age received a first kidney transplant at our center. Baseline characteristics are presented in Table 1 . Sixteen patients (10%) were transplanted preemptively. Median follow-up time was 5.1 years (range 0.1-9.7). All patients received steroids. One hundred and forty-eight patients (93%) received CsA, 137 patients (86%) received MMF and 38 patients (24%) received IL2R-ab. Median cold ischemia time was 12 h (range 1-28). Forty-eight patients (30%) experienced delayed graft function, defined as the need for dialysis in the first 7 days after transplantation including primary non-functioning grafts. Thirty-five patients (22%) were treated for biopsy proven acute rejection episode during the first 90 days after transplantation. Twenty-two patients had known DM at time of transplantation, but only seven were registered with diabetes nephropathy as the cause of kidney failure. Of the 138 patients without pre-existing DM at time of transplantation, 30 patients (22%) were discharged to their local center before the OGTT at 10 weeks. Five patients (4%) died before the planned OGTT, and seven patients (18%) did not perform OGTT. The remaining 96 patients without pretransplant DM were categorized according to the results of the OGTT (Figure 1) . Baseline clinical characteristics comparing patients with normal OGTT and patients having IGT and NODAT are presented in Table 2 .
No patient was lost to follow-up. Eighty-seven patients (54%) died during the observation period. Median survival time in the total study population was 7.9 years [95% confidence interval (CI) 6.3-9.5 years]. Sixty-nine patients Figure 2 . The survival curves are dividing after~1 year; 5 years survival was estimated to 83% for patients with normal glucose tolerance and 71% for patients with IGT or NODAT (log rank P ¼ 0.002). A separate survival analysis comparing all patients with (N ¼ 22) and without (N ¼ 138) pre-transplant DM, revealed an estimated 5-year survival of 50% for patients with pre-existing DM compared to 66% for patients without DM (log rank P ¼ 0.012). Kaplan-Meier plots illustrating uncensored and death censored graft survival are shown in Figures 3 and 4 . Variables tested in uni-and multivariable Cox regression models for association with patient survival and the results of the analyses are presented in Table 3 .
Similar models for uncensored graft survival (90 events) and death censored graft survival (21 events) were also analyzed. In the multivariable model, age (HR 1.10 per year, 95% CI 1.02-1.19. P ¼ 0.013) and pre-transplant DM (HR 1.98, 95% CI 1.15-3.41, P ¼ 0.013) were found to be associated with uncensored graft loss. Age (HR 1.29, 95% CI 1.09-1.52, P ¼ 0.002), donor age ! 60 years (HR 2.65, 95% CI 1.01-6.96, P ¼ 0.047), female gender (HR 0.29, 95% CI 0.11-0.77, P ¼ 0.013) and delayed graft function (HR 5.86, 95% CI 2.03-16.94, P ¼ 0.001) were associated with death censored graft loss. Recipients who lost their graft function and returned to dialysis had significant inferior survival compared to recipients who retained lifelong graft function. A comparative Kaplan-Meier analysis revealed an estimated 5-year patient survival after transplantation of only 25% among recipients who lost their graft versus 69% among those who retained lifelong graft function (log rank P < 0.001).
A possible association between graft function, expressed as creatinine values at 1 year after transplantation, and the 
Discussion
In kidney transplant recipients !70 years of age at transplantation, the multivariable model analyses reveal that recipient age, presence of pre-transplant DM and time on dialysis before transplantation were significantly associated with survival after transplantation. Comorbidity expressed by the Charlson Comorbidity Index showed no such association. From previous publications, it seems reasonable that diabetes should have an impact on the outcome after transplantation [8] . The effects of age and DM in our Cox regression analyses were, however, modest and give in our opinion no argument for excluding elderly ESRD patients with DM from transplantation as long as they fulfill the medical requirements in a standard pre-transplant work-up. An interesting finding was that previously non-diabetic patients with IGT or NODAT at 10 weeks post-transplant had significantly inferior survival compared to those with normal OGTT. This is in line with previous analyses of adult recipients [9] and strengthens the impression that IGT and DM indeed are important comorbidities also in elderly recipients. A post transplant OGTT can, however, not be used to deny patients a transplantation, and the outcome of elderly patients with impaired glucose metabolism does therefore need further investigation. In a previous study of adult kidney transplant recipients from our center, the authors described a significant association between pre-transplant pathological OGTT and post-transplant hyperglycemia [12] . Unfortunately, information about pretransplant OGTT was not available for all patients, but it will definitely be of particular interest in a further prospective study to investigate whether this association is also present in an elderly population. The most important scope will, however, be to investigate a possible association between pre-transplant pathological OGTT and survival, as this association may be used in the selection of patients. In contrast to our previous analyses [10] , presence of early rejections was no longer associated with impaired patient survival. The negative impact of advanced donor age was also eliminated. These differences are most certainly caused by the major reduction in acute rejection episodes that has emerged with the present immunosuppressive regimen. This raises the possibility that the negative impact of donor age is related to increased immunogenicity of old kidneys thereby provoking rejections [13] . In addition, older kidneys may have less potential to 'survive' an acute rejection than younger and more vital transplants. A likely interpretation of the present study is that our current immunosuppressive strategy has 'enough' immunosuppression to avoid rejections also in elderly patients [14] . On the other hand, too much immunosuppression may harm the patient by increasing risk of infection and malignancies [15, 16] . The SYMPHONY study showed us that it is possible to reduce the target concentration levels of calcineurin inhibitors (CNIs) without negative impact on acute rejection rate or survival [17] . Accordingly, our present regimen with basiliximab induction, low dose CNI, MMF and steroids appears appropriate. Generally, with a low incidence of risk factors, any associations to end points are difficult to detect. In this analysis, the incidence of rejection episodes was 22%. In our former analysis of transplant outcomes in elderly patients, 40% of the recipients had an early acute rejection episode. It may be argued that the lower number of rejections in this series had too little power to detect any association to outcomes. Another possibility is that the association between rejections and outcomes in the previous report was caused by 'noise' from the frequent occurring rejection episodes. In any case, the present data stresses the importance of repeated analyses performed on different populations to ascertain representative clinical significant variables.
Graft function expressed as creatinine value at 1 year after transplantation was identified in univariable Cox regression models as a variable with possible association with both patient and graft survival. These findings have to be taken with concern as there were some missing values in the analyses. They do, however, support similar findings in previous studies [18, 19] , and the importance of achieving a good graft function is stressed.
The present study has several limitations. The retrospective observational design makes it difficult to draw firm conclusions regarding causal inferences. The potential of an observational study to make causal inferences is less compared to a randomized controlled trial [20, 21] . Additionally, with a retrospective design, it is important that the groups compared are as equal as possible. One-third of the patients did not perform a routine OGTT and more healthy patients may have been selected to undergo this test. Patients with new onset IGT or diabetes were older and tended to have received kidneys from older donors ( Table 2 ). These findings bear implications for the interpretation of the data and highlight the need for further study before firm conclusions can be drawn.
The study also has several strengths. It is performed using data from a single transplant center, which is to our knowledge one of the world's leading centers of kidney transplantation in elderly patients [22] . The database is also complete for all patients.
Conclusion
In elderly candidates with ESRD who fulfill the criteria for acceptance for transplantation, it seems important to provide a kidney early to avoid or limit the time on dialysis. Recipients with known DM are at some increased risk, but in our opinion, transplantation is still an option for these patients.
